Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

Neurodegenerative diseases such as Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) dementia are devastating conditions caused by the accumulation of toxic proteins in the brain. Drugs designed to reduce the levels of these proteins and modify the course of disease are being aggressively developed [1x[1]Reiman, E.M. Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test. Nat Rev Neurol. 2017;
13: